Register entry

Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: BLA 3.

Dosage formNDCs
kit3
RouteNDCs
intravenous3
Labeller name on the listingNDCs
laboratoire franais du fractionnement et des biotechnologies socit anonyme (lfb s.a.)3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
SevenfactCoagulation Factor VIIa Recombinant Humankit, intravenous71127-1000BLA
SevenfactCoagulation Factor VIIa Recombinant Humankit, intravenous71127-2000BLA
SevenfactCoagulation Factor VIIa Recombinant Humankit, intravenous71127-5000BLA
Enquiry

Common questions

Is Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) FDA approved?
Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) make?
3 products are listed under Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.